InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

- Current share price for 4DX : $4.070

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,448 Notification of cessation of securities - 4DX 2 Oct 2026 4:22PM $4.340 $4.070 fallen by 6.22%
$2,448 Application for quotation of securities - 4DX 2 Oct 2026 4:20PM $4.340 $4.070 fallen by 6.22%
$2,448 Ceasing to be a substantial holder 28 Sep 2026 8:16AM $4.000 $4.070 risen by 1.75%
$2,448 Becoming a substantial holder 25 Sep 2026 8:12AM $4.100 $4.070 fallen by 0.73%
$2,448 Notice of Annual General Meeting/Proxy Form 24 Sep 2026 9:37AM $4.080 $4.070 fallen by 0.25%
$2,448 Appendix 4G and Corporate Governance Statement 24 Sep 2026 9:28AM $4.080 $4.070 fallen by 0.25%
$2,448 FY26 Annual Report 24 Sep 2026 9:19AM $4.080 $4.070 fallen by 0.25%
$2,448 Initial Director's Interest Notice - CJ 23 Sep 2026 6:53PM $4.080 $4.070 fallen by 0.25%
$2,448 Board transition and key personnel appointments 23 Sep 2026 6:50PM $4.080 $4.070 fallen by 0.25%
$2,448 Ceasing to be a substantial holder 23 Sep 2026 8:16AM $3.990 $4.070 risen by 2.01%
$2,448 Application for quotation of securities - 4DX 18 Sep 2026 3:47PM $4.220 $4.070 fallen by 3.55%
$2,448 Cleansing Notice 4 Sep 2026 4:11PM $3.600 $4.070 risen by 13.06%
$2,448 Application for quotation of securities - 4DX 4 Sep 2026 4:04PM $3.595 $4.070 risen by 13.21%
$2,448 Notification of Date of 2026 AGM 28 Aug 2026 3:17PM $3.630 $4.070 risen by 12.12%
$2,448 FY2026 Full year results 28 Aug 2026 11:04AM $3.755 $4.070 risen by 8.39%
$2,448 Appendix 4E - Preliminary Final Report 28 Aug 2026 10:58AM $3.770 $4.070 risen by 7.96%
$2,448 Application for quotation of securities - 4DX 14 Aug 2026 4:00PM $3.660 $4.070 risen by 11.20%
$2,448 Cleansing Notice 13 Aug 2026 4:43PM $3.910 $4.070 risen by 4.09%
$2,448 Application for quotation of securities - 4DX 13 Aug 2026 4:37PM $3.910 $4.070 risen by 4.09%
$2,448 Update - Proposed issue of securities - 4DX 10 Aug 2026 4:44PM $4.400 $4.070 fallen by 7.50%
$2,448 Update - Proposed issue of securities - 4DX 31 Jul 2026 4:46PM $3.630 $4.070 risen by 12.12%
$2,448 Quarterly Activity Report and Appendix 4C 31 Jul 2026 10:13AM $3.330 $4.070 risen by 22.22%
$2,448 Change in substantial holding 20 Jul 2026 6:17PM $3.430 $4.070 risen by 18.66%
$2,448 US Bill directs VA to adopt 4D lung imaging 16 Jul 2026 12:31PM $3.910 $4.070 risen by 4.09%
$2,448 Trading Halt 16 Jul 2026 10:45AM $3.910 $4.070 risen by 4.09%

1 - 25 of 607 results

Page 1 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.